Why the study?
Does diphenylhydantoin induce supraventricular tachycardia in a patient with hypothyroidism and rheumatic heart disease?
Does diphenylhydantoin induce supraventricular tachycardia in a patient with hypothyroidism and rheumatic heart disease?
This case report highlights a potential risk of diphenylhydantoin-induced supraventricular tachycardia in patients with hypothyroidism and underlying heart disease.
Answers are grounded in this paper and cite their sources.
May signal SVT risk with diphenylhydantoin in hypothyroidism and rheumatic heart disease; hypothesis-generating, leaves causality open.
WE HAVE RECENTLY seen a patient with hypothyroidism and heart disease who developed supraventricular tachycardia following the administration of diphenylhydantoin. The use of this drug for treatment of cardiac arrhythmias has received favorable attention¹,²and so the circumstances in this case are of interest. Report of a Case A 53-year-old white woman with rheumatic heart disease had a mitral commissurotomy in 1954. Although euthyroid, she was given an ablative dose of sodium iodide 1131 in 1955 in an effort to slow her heart rate. With the development of symptomatic hypothyroidism, she was given thyroid replacement therapy. She took sodium levothyroxine (Synthroid) (0.15 mg) daily and quinidine sulfate (0.3 gm) three times a day during the year before the present hospitalization, and digoxin (0.25 mg) daily during the preceding month. She was hospitalized in May 1965 because of the renewed appearance of atrial flutter with 2:1 to 4:1 atrioventricular (AV)
No takes yet. Share an insight, caveat, or question.
Milford Fulop (1966) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: